4848.0000 -20.50 (-0.42%)
NSE Jun 05, 2025 13:14 PM
Volume: 72,209
High vol. this week

4848.00
-0.42%
Motilal Oswal
With an established presence in the Domestic Formulation (DF) segment and exports, ALKEM is boosting its growth prospects in the bio-CDMO and med-tech segments. The overall investment in the bio-CDMO segment is expected to be ~INR14b.
Alkem Laboratories Ltd. is trading below all available SMAs
More from Alkem Laboratories Ltd.
Recommended